Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI

被引：2
|
作者：
Vavuranakis, Manolis [1 ,2 ]
Boudoulas, Konstantinos D. [2 ]
Katsarou, Ourania [1 ]
Vrachatis, Dimitrios A. [1 ]
Kalogeras, Konstantinos I. [1 ]
Papaioannou, Theodore G. [1 ]
Siasos, Gerasimos [1 ]
Oikonomou, Evangelos [1 ]
Lazaros, George [1 ]
Vavuranakis, Michael-Andreas [1 ]
Deftereos, Spyridon [3 ,4 ]
Tousoulis, Dimitrios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Dept Cardiol 1, Athens, Greece
[2] Ohio State Univ, Dept Cardiovasc Med, Columbus, OH 43210 USA
[3] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Cardiol 2, Athens, Greece
[4] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
来源：
CURRENT PHARMACEUTICAL DESIGN | 2017年 / 23卷 / 09期
关键词：
ASD; LAA; PFO; transcatheter; warfarin; coumadin; antiplatelet; NOAC; LEFT ATRIAL APPENDAGE; PATENT FORAMEN OVALE; TRANSCATHETER OCCLUSION PLAATO; TRANSIENT ISCHEMIC ATTACK; 2010 ESC GUIDELINES; HIGH-RISK PATIENTS; PERCUTANEOUS CLOSURE; STROKE PREVENTION; PARADOXICAL EMBOLISM; ORAL ANTICOAGULANTS;
D O I：
10.2174/1381612822666161221143416
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Transcatheter interventions for structural heart disease represent an emerging field in interventional cardiology. Undoubtedly, there is an absolute necessity for antiplatelet and/or anticoagulation treatment prior, during and post such interventions. However, currently administered regimens are mainly based in expert consensus recommendations. In the present review we aim to summarize data regarding anti platelet and/or anticoagulation treatment in the following transcatheter structural heart interventions: left atrial appendage closure, atrial septal defect closure, patent foramen oval closure, paravalvular leak closure.
引用
收藏
页码：1328 / 1333
页数：6
相关论文
共 50 条
  • [1] Antiplatelet therapy in valvular and structural heart disease interventions
    Nusca, Annunziata
    Bressi, Edoardo
    Colaiori, Iginio
    Miglionico, Marco
    Di Sciascio, Germano
    [J]. CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2018, 8 (05) : 678 - 693
  • [2] Antiplatelet Therapy and Anticoagulation in Patients with coronary Heart Disease
    Liedtke, Jan-Patrick
    Ahrens, Ingo
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (16) : 1041 - 1050
  • [3] Cardiac CT and Structural Heart Disease Interventions (Non-TAVI)
    Christina Tan
    Dee Dee Wang
    Mark Reisman
    Jacqueline Saw
    [J]. Current Cardiovascular Imaging Reports, 2019, 12
  • [4] Cardiac CT and Structural Heart Disease Interventions (Non-TAVI)
    Tan, Christina
    Wang, Dee Dee
    Reisman, Mark
    Saw, Jacqueline
    [J]. CURRENT CARDIOVASCULAR IMAGING REPORTS, 2019, 12 (10)
  • [5] Anticoagulation and antiplatelet therapy in patients with prosthetic heart valves
    Aikins, Joel
    Koomson, Abeku
    Ladele, Mofolaoluwami
    Al-Nusair, Lana
    Ahmed, Amna
    Ashry, Amr
    Harky, Amer
    [J]. JOURNAL OF CARDIAC SURGERY, 2020, 35 (12) : 3521 - 3529
  • [6] Antiplatelet and anticoagulation therapy during percutaneous coronary interventions: A review for the interventionalist
    Basman, Craig
    Tariq, Afnan
    Parmar, Yuvrajsinh J.
    Asti, Deepak
    Coplan, Neil L.
    Singh, Varinder P.
    Reimers, Carl D.
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2018, 31 (05) : 693 - 704
  • [7] Impact of Antiplatelet Therapy in Heart Disease
    Renda, Giulia
    de Caterina, Raffaele
    [J]. ANTIPLATELET THERAPY IN ACS AND A-FIB, 2012, 47 : 5 - 19
  • [8] Antiplatelet therapy for ischemic heart disease
    Lange, RA
    Hillis, LD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (03): : 277 - 280
  • [9] Dual Antiplatelet Therapy for Heart Disease
    Carreras, Edward T.
    Mega, Jessica L.
    [J]. CIRCULATION, 2014, 129 (21) : E506 - E508
  • [10] Antiplatelet therapy for ischemic heart disease
    Steimle, AE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (20): : 2101 - 2102
12345